Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
astrazeneca
8
×
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
8
×
indiana blog main
indiana top stories
life sciences
national
8
×
national blog main
national top stories
new york blog main
new york top stories
pfizer
8
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
8
×
texas top stories
wisconsin blog main
wisconsin top stories
fda
merck
abbvie
bristol-myers squibb
startups
alzheimer's disease
cancer
cancer immunotherapy
deals
eli lilly
investing
What
bio
roundup
drug
cancer
amid
annual
biotech
bombast
caught
conference
coronavirus
debate
develop
discussion
efforts
esmo
fda
meso’s
miss
news
pandemic
pfizer’s
presidential
prices
promise
response
seven
tuesday’s
vaccine
viewers
week
acquisitions
alzheimer’s
approved
ash
assessed
attention
august
away
barcelona
Language
unset
Current search:
astrazeneca
×
pfizer
×
" texas blog main "
×
" detroit top stories "
×
national
×
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
ESMO 2019: PARP and Prostate, SeaGen’s Win, KRAS Update & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More